Data is not available at this time.
AMA Corporation Plc operates in the healthcare information services sector, specializing in remote assistance solutions through its XpertEye platform. The company serves industrial organizations, service providers, and medical institutions globally, offering software that integrates with smartphones, tablets, smart glasses, and other connected devices. Its product suite, including XpertEye Lite, Essential, Advanced, Proceed, and Schedule, supports remote training, inspections, and real-time assistance, positioning it as a niche player in assisted reality technology. The company’s focus on industrial and medical applications differentiates it from broader SaaS providers, though its small scale limits direct competition with larger healthcare IT firms. Market adoption hinges on the growing demand for remote collaboration tools, particularly in sectors requiring specialized technical support. Headquartered in Rennes, France, AMA Corporation faces challenges in scaling its solutions against entrenched competitors but benefits from first-mover advantages in certain verticals.
AMA Corporation reported revenue of €2.49 million for the period, reflecting its early-stage growth trajectory. However, net losses of €7.34 million and negative operating cash flow of €6.28 million highlight significant profitability challenges. Capital expenditures were minimal at €106,000, suggesting a lean operational model focused on software development rather than physical infrastructure. The company’s high beta of 3.095 indicates pronounced volatility, likely tied to its unproven financial performance and niche market focus.
Diluted EPS of -€0.199 underscores the company’s current lack of earnings power, with losses outweighing revenue generation. Negative operating cash flow further signals inefficiency in converting sales into sustainable liquidity. The absence of dividend payouts aligns with its reinvestment needs, though persistent losses raise questions about capital allocation effectiveness. The modest cash balance of €5.82 million relative to total debt of €4.03 million limits financial flexibility.
AMA Corporation’s balance sheet shows €5.82 million in cash against €4.03 million in total debt, yielding a net cash position but with limited runway given operating losses. The equity base is small, with a market cap of €10.65 million, reflecting investor skepticism. While not immediately distressed, the company’s reliance on future funding or operational turnaround to sustain operations is evident.
Growth prospects hinge on broader adoption of remote assistance tools, though current revenue levels remain insufficient to offset costs. No dividends are paid, consistent with its reinvestment priorities. The company’s ability to scale its platform and reduce losses will be critical to attracting further investment or achieving breakeven. Market trends favor digital healthcare solutions, but execution risks persist.
The €10.65 million market cap suggests minimal investor confidence, likely due to sustained losses and high beta. Valuation multiples are inapplicable given negative earnings, leaving future pricing contingent on revenue acceleration or cost containment. The niche focus may appeal to specialized investors, but broader market appeal remains unproven without clearer profitability pathways.
AMA Corporation’s assisted reality platform addresses underserved industrial and medical use cases, offering differentiation in a crowded tech landscape. However, its small scale and financial constraints limit competitive moats. Success depends on securing strategic partnerships or achieving critical mass in key verticals. Near-term outlook remains uncertain, with liquidity and operational efficiency as decisive factors.
Company description and financial data sourced from publicly disclosed ticker information.
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |